Nebraska Hematology-Oncology

Lincoln, Nebraska 68506-7548

4 studies enrolling now · 10 studies all time

What they study most

BRAF Gene Mutation, Bladder Cancer, Breast Cancer, Cholangiocarcinoma, Chronic Lymphocytic Leukemia, Colorectal Cancer, Coronavirus, ERK Mutation, Early-Stage Breast Carcinoma, Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer — Recruiting now
• A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors — Recruiting now
• First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. — Recruiting now
• Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies — Available (expanded access)
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
• Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer — Stopped early
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer — Completed